Actionable news
All posts from Actionable news
Actionable news in NVS: NOVARTIS AG,

Novartis (NVS) Earnings Report: Q3 2015 Conference Call Transcript

The following Novartis (NVS - Get Report) conference call took place on October 27, 2015, 09:00 AM ET. This is a transcript of that earnings call:

Company Participants

  • Joseph Jimenez; Novartis; CEO
  • Samir Shah; Novartis; Global Head, IR
  • Harry Kirsch; Novartis; CFO
  • David Epstein; Novartis; Division Head, Pharmaceuticals
  • Jeff George; Novartis; Division Head, Alcon
  • Richard Francis; Novartis; Division Head, Sandoz
  • Felix Ehrat; Novartis; General Counsel

Other Participants

  • Alexandra Hauber; UBS; Analyst
  • Andrew Baum; Citigroup; Analyst
  • Richard Vosser; JPMorgan; Analyst
  • Matthew Weston; Credit Suisse; Analyst
  • Tim Race; Deutsche Bank; Analyst
  • Tim Anderson; Bernstein; Analyst
  • Graham Parry; BofA Merrill Lynch; Analyst
  • Florent Cespedes; Societe Generale; Analyst
  • Amy Walker; Morgan Stanley; Analyst
  • Michael Leuchten; Barclays Capital; Analyst
  • Simon Baker; Exane; Analyst
  • Naresh Chouhan; Liberum Capital; Analyst
  • Keyur Parekh; Goldman Sachs; Analyst

MANAGEMENT DISCUSSION SECTION Operator: Welcome to the Novartis Q3 2015 results conference call and live audio webcast.


(Operator Instructions) The recording of the conference call including the Q&A session are available on our website shortly after the call ends. With that, I would like to hand over to Mr. Joe Jimenez, CEO of Novartis. Please go ahead, sir. Joseph Jimenez (CEO): Thank you and welcome to our third quarter...